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Abstract
Background: Until now, cardiometabolic risk assessment in Dutch primary health care was directed at case-finding,
and structured, programmatic prevention is lacking. Therefore, the Prevention Consultation cardiometabolic risk
(PC CMR), a stepwise approach to identify and manage patients with cardiometabolic risk factors, was
developed. The aim of this study was 1) to evaluate uptake rates of the two steps of the PC CMR, 2) to assess
the rates of newly diagnosed hypertension, hypercholesterolemia, diabetes mellitus and chronic kidney disease
and 3) to explore reasons for non-participation.
Methods: Sixteen general practices throughout the Netherlands were recruited to implement the PC CMR
during 6 months. In eight practices eligible patients aged between 45 and 70 years without a cardiometabolic
disease were actively invited by a personal letter (‘active approach’) and in eight other practices eligible patients
were informed about the PC CMR only by posters and leaflets in the practice (‘passive approach’). Participating
patients completed an online risk estimation (first step). Patients estimated as having a high risk according to
the online risk estimation were advised to visit their general practice to complete the risk profile with blood
pressure measurements and blood tests for cholesterol and glucose and to receive recommendations about risk
lowering interventions (second step).
Results: The online risk estimation was completed by 521 (33%) and 96 (1%) of patients in the practices with an
active and passive approach, respectively. Of these patients 392 (64%) were estimated to have a high risk and
were referred to the practice; 142 of 392 (36%) consulted the GP. A total of 31 (22%) newly diagnosed patients
were identified. Hypertension, hypercholesterolemia, diabetes and chronic kidney disease were diagnosed in
13%, 11%, 1% and 0%, respectively. Privacy risks were the most frequently mentioned reason not to participate.
Conclusions: One third of the patients responded to an active invitation to complete an online risk estimation.
A passive invitation resulted in only a small number of participating patients. Two third of the participants of
the online risk estimation had a high risk, but only one third of them attended the GP office. One in five visiting
patients had a diagnosed cardiometabolic risk factor or disease.
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Background
This article reports data that has already been published
in Dutch [1]. This has been reproduced in English, with
permission from the copyright holder.
In the Netherlands (total population almost 17 million)
more than 1 million people have cardiovascular disease,
about 740.000 have diabetes and about 40.000 have
chronic kidney disease ((pre)dialysis or transplantation)
[2]. Mortality rates due to ischaemic heart disease and
stroke are low compared to the rest of Europe (top-3 and
top-4, respectively) [3]. Cardiovascular disease, diabetes
mellitus and chronic kidney disease (further referred to as
“cardiometabolic disease”) and cardiovascular mortality
are highly associated with modifiable lifestyle factors such
as smoking, physical inactivity and poor diet [4,5]. In the
Netherlands, more than a quarter of the population cur-
rently smokes and about half of all people are overweight
or obese [6,7]. These risk factors, together with biomedical
indices such as glucose and cholesterol levels, blood pres-
sure level and the family history of cardiometabolic dis-
ease [8] generate a personal risk profile which predicts the
future development of cardiovascular disease and diabetes
mellitus. In addition, the metabolic syndrome, with the
hypertriglyceridaemic waist as its most prominent clinical
criterion, is a contributing factor to global cardiometabolic
risk [9].
Self-tests for glucose and cholesterol assessments and
home devices for measuring blood pressure have become
commercially available [10], but in the Netherlands no
evidence-based cardiometabolic screening program exists
within current medical practice. So far, cardiometabolic
risk assessment in primary health care has been directed
at case-finding, and structured, programmatic prevention
is lacking.
General practitioners report to have a positive attitude
towards preventing cardiometabolic disease, but they
emphasize that screening should be directed at the group
of patients with the highest cardiometabolic risk [11].
Therefore the Dutch College of General Practitioners, the
National Association of General Practitioners and the
Netherlands Society of Occupational Medicine together
with three health foundations (Netherlands Heart Founda-
tion, Dutch Diabetes Research Foundation and Dutch Kid-
ney foundation) developed the guideline Prevention
Consultation cardiometabolic risk (PC CMR) [2]. The
PC CMR is based on current evidence regarding
cardiometabolic risk estimation and comprises of a
stepwise approach. Based on an online risk estimation
(first step), high risk patients are referred to the gen-
eral practice (second step), where the risk profile is
completed and appropriate interventions are initiated.
The prototype of the PC CMR was implemented in 16
general practices throughout the Netherlands for a
period of 6 months. Aims of the study were 1) to
evaluate uptake rates of the two steps of the PC CMR; 2)
to assess the rates of newly diagnosed patients with hyper-
tension, hypercholesterolemia, diabetes and chronic kid-
ney disease at risk for cardiometabolic disease; and 3) to
explore reasons for non participation.
Methods
Patients
Sixteen general practices (49 general practitioners (GPs)
and 27 practice nurses) were recruited who were willing
to implement the prototype of the PC CMR. Eligible pa-
tients were aged between 45 and 70 years and had no
cardiovascular disease, diabetes mellitus and/or chronic
kidney disease according to their electronic patient rec-
ord (Table 1). In the Netherlands, GPs have a fixed prac-
tice list, and all non-institutionalized inhabitants are
obligatory listed in a general practice.
Eight practices identified all eligible patients born in
1939, 1946, 1952, 1958 or 1964, sent them a personal
letter and invited them to complete the online risk esti-
mation (‘active approach’). This selection procedure was
based on practical reasons regarding implementation. By
choosing 5 birth cohorts spread out over the actual age
of 45 – 70 years, we were able to reach a wide age range
and participating GPs had a practical and uniform tool
to invite their patients. It was not feasible for participa-
ting GPs to invite all persons between 45–70 years, since
Table 1 Exclusion criteria for prevention consultation
cardiometabolic risk (ICPC-codes [International
classification of primary care]) (not reported previously)
ICPC code Title
K74 Ischaemic heart disease with angina pectoris
K75 Acute myocardial infarction
K76 Ischaemic heart diseases without angina pectoris
K77 Heart failure
K78 Atrial fibrillation
K79 Paroxysmal tachycardia
K82 Pulmonary heart disease
K83 Heart valve disease
K84 Other disease of heart
K86 Uncomplicated hypertension
K87 Hypertension with involvement target organs
K89 Transient cerebral ischemia
K90 Stroke/cerebrovascular accident
K91 Atherosclerosis
K92 Peripheral vascular diseases
T90 Diabetes mellitus
T93 Lipid metabolism disorder
U88 Glomerulonephritis/nephrosis
U99 Other disease urinary system
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all GPs had their regular GP practice duties and ac-
tivities. The first invitation letter was sent between
October 2009 and January 2010. A reminder letter
was sent in March 2010.
The eight other practices passively invited all eligible
patients by a poster in the waiting room of the practice
and by leaflets in the waiting room and consulting room
(‘passive approach’). The poster and leaflets contained
information on the purpose of the PC CMR and invited
patients to complete the online risk estimation. Poster
and leaflets were present between October 2009 and
May 2010.
A medical ethics committee approval was not required
according to Dutch legislation.
PC CMR
The first step of the PC CMR is an online risk estima-
tion. The online risk estimation was offered in a non-
secure, open web environment.
The online risk estimation consists of a web-based
questionnaire on risk factors for cardiovascular disease,
diabetes mellitus and chronic kidney disease [12]. The
questionnaire contains three items of the Systematic
Coronary Risk Evaluation (SCORE) risk function: age,
gender and smoking status [13] and all items of the
Finnish Diabetes Risk Score (FINDRISK): height, weight,
waist circumference, history of high blood glucose and
family history of diabetes mellitus [14]. Body mass index
(weight (kg)/height2 (m2)) was derived from the web-
based questionnaire. Since a positive family history dou-
bles the future risk, a question on family history of car-
diovascular disease was added [8]. A positive family
history of cardiovascular disease was defined as a first
degree relative with cardiovascular disease below the age
of 65 years. Based on the algorithm in Figure 1 partici-
pants were categorized as having a low, intermediate or
high risk for cardiometabolic disease.
In the second step of the PC CMR, patients estimated
as having high risk according to the online risk estima-
tion are advised to visit their general practice in order to
complete their risk profile and discuss follow-up treat-
ment. The risk profile includes assessments of serum
cholesterol ratio (total cholesterol: HDL), serum glucose
level and blood pressure measurements.
Measurements
Uptake and participation
A representative of each general practice (either a gen-
eral practitioner or practice nurse) identified the eligible
population (patients between 45 and 70 years without
cardiometabolic disease) by using the electronic medical
records. An anonymised list of the eligible population
was sent to the researchers.
Results of the online risk estimations, completed by
the participants, were saved in a web-based log file.
From the log file, which contained all answers to the
questions of the online risk estimation, we were able to
calculate the uptake of the first step of the PC CMR and
Age ≥ 60 yrs
Positive family
history CVD
Smoking
Findrisk ≥ 10
Findrisk 7, 8, or 9
OR
Positive family history CVD and age < 45 yrs
OR
Smoking and age < 50 yrs (men)
Smoking and age < 55 yrs (women) Low risk
Age ≥ 45 yrs
≥ 50 yrs (men)
≥ 55 yrs (women)
Intermediate risk
High risk
yes
yes
yes
yes
yes
no
no
no
yes
yes
Figure 1 Algorithm for estimating cardiometabolic risk (not published previously).
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to categorize the participants as having low, intermediate
or high risk. Response rates to the second step of the PC
CMR were calculated on the basis of the GP’s insurance
claims of practice visits.
Cardiometabolic disease
After the study period of 6 months, GPs provided data
from the electronic medical records of patients who
consulted the practice on the basis of the estimated high
risk at the online risk estimation. GPs reported the pres-
ence or absence of hypertension, hypercholesterolemia,
diabetes mellitus and chronic kidney disease. Additionally,
they reported results of diagnostic assessments and
laboratory tests on blood pressure, serum cholesterol,
LDL and HDL levels, serum glucose, glycated hemoglobin,
serum creatinine, creatinine clearance according to the
Modification of Diet in Renal Disease (MDRD) formula
[15] and urine albumin-to-creatinine ratio. Finally, new
prescriptions for antihypertensive medication, statins and
oral antidiabetics were reported.
Reasons for non-response
We conducted a survey among the eligible population in
order to evaluate differences between responders and
non-responders. A questionnaire was sent to all eligible
patients in the practices that had used the ‘active ap-
proach’, and to a random sample of 200 persons of the
eligible population in practices that had invited patients
passively. The questionnaire contained items on demog-
raphy, health risk behaviour and attitudes towards the
PC CMR. Alcohol use of >6 drinks/day was used to de-
scribe the proportion of participants with excessive alco-
hol abuse [16].
Statistical analysis
We evaluated uptake rates and the incidence of
cardiometabolic disease as a percentage of the eligible
population. Additionally, we reported the number needed
Table 2 Results from the online risk estimation; means
and percentages (not reported previously)
Approach P value
Active
(n = 521)
Passive
(n = 96)
Age, years, mean 54,5 55,7 0,17
BMI, kg/m2, mean 25.4 26.8 <0,01
Gender, n (%)
Male 216 (41,5%) 41 (42,7%) 0,82
Female 305 (58,5%) 55 (57,3%)
Waist circumference
man, n (%)
< 94 cm 50 (23,2%) 12 (29,3%) 0,33
94 – 102 cm 101 (46,8%) 14 (34,2%)
> 102 cm 65 (30,1%) 15 (36,6%)
Waist circumference
woman, n (%)
< 80 cm (%) 42 (13,8%) 8 (14,6%) 0,96
80 – 88 cm (%) 106 (34,8%) 18 (32,7%)
> 88 cm (%) 157 (51,5%) 29 (52,7%)
Ever high blood
glucose or
diabetes, n (%)
Yes 33 (6,3%) 3 (3,1%) 0,22
No 488 (93,7%) 93 (96,9%)
Family history of
diabetes, n (%)
Yes 143 (27,5%) 30 (31,3%) 0,45
No 378 (72,6%) 66 (68,8%)
Family history of
cardiovascular
disease, n (%)
Yes 134 (25,7%) 32 (33,3%) 0,12
No 387 (74,3%) 64 (66,7%)
Smoking, n (%)
Yes 109 (20,9%) 20 (20,8%) 0,98
No 412 (79,1%) 76 (79,2%)
Table 3 Diagnostic test results, diagnoses and prescribed
medication of 142 GP office visitors; percentages, and
calculated number to screen among high risk patients
(not reported previously)
Based on N Identified N (%) NNS*
Blood pressure
Hypertension 142 18 (12.7%) 7.9
Systolic blood
pressure ≥180 mmHg
131 5 (3.8%) 26.2
Cholesterol
Hypercholesterolemia 142 15 (10.6%) 9.5
Cholesterol≥ 8.0 mmol/l
or cholesterol/HDL-ratio≥ 8.0
126 5 (4.0%) 25.5
Glucose
Diabetes mellitus 142 2 (1.4%) 70.9
Impaired Fasting Glucose
(≥6.1 and ≤6.9 mmol/l)
120 14 (11.7%) 8.6
Kidney function
Chronic kidney disease 142 0 (0%) ∞
Urine albumin-to-creatinine
ratio >3.5 mg/mmol
49 2 (4.1%) 24.5
Medication
Antihypertensive agents 142 11 (7.8%) 12.9
Statins 142 5 (3.5%) 28.4
Blood glucose lowering drugs 142 3 (2.1%) 47.4
* NNS: Number needed to screen.
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to screen (NNS) as the inverse of the proportion of pa-
tients diagnosed with a cardiometabolic disease.
We calculated statistical differences between participants
and non-participants by two sample Student t-tests for con-
tinuous outcomes and Chi-square tests for dichotomous
outcomes. We used the statistical software package STATA
10.0 (StataCorp; College Station TX, US).
Results
All results have been previously reported in Dutch [1],
except for Tables 2 and 3 and Figure 1.
Uptake and cardiometabolic disease
In the 8 practices using the active approach, 1,583 pa-
tients received an invitation letter to participate in the
PC CMR. Of these, 521 (32.9%) completed the online
risk estimation (Figure 2). Their mean age was 54 years
and 59% were women. In 283 (54.3%) cases the online
questionnaire was completed after the date a reminder
letter was sent.
The eligible population in the 8 practices using the
passive approach consisted of 8,313 patients. Ninety-six
(1.2%) patients completed the online risk estimation
(Figure 2). Their mean age was 56 years and 57% were
women. Their age and gender did not statistically significantly
differ from participants in the active approach (p = 0.17 and
p= 0.82, respectively).
Table 2 shows the results of the online risk estimation.
Participants from practices with the passive approach
had a higher body mass index than patients from prac-
tices in the active approach (25.4 versus 26.8, p < 0.01).
Of all participants, 129 (21%) smoked, 253 (41%) were
overweight (BMI ≥ 25 and <30), 74 (12%) were obese,
and 36 (6%) had a history of high blood glucose or dia-
betes mellitus. A positive family history of diabetes
mellitus and cardiovascular disease was reported by 173
(28%) and 166 (27%), respectively.
A total of 392 (63.5%) participants had a high risk for
cardiometabolic disease, based on the online risk estima-
tion; 83 (13.5%) and 142 (23.0%) participants had an
intermediate or low risk, respectively. There was no sta-
tistically significant difference of the distribution of esti-
mated risk profiles between the participants in the two
types of practices.
Only patients with a high risk score were advised to
visit the practice. A total of 142 participants visited the
practice. Nine percent of the visitors had a low or inter-
mediate score at the online risk estimation, but never-
theless visited the GP office despite the negative advice.
Results of diagnostic tests, and prescribed medication
Active invitation
8 General practices
1583 Patients
Completed on-line risk
estimation
N = 521 (32.9%)
High risk score at screening
N = 327 (20.7%)
Attendance at general practice
N = 131 (8.3%)
Passive invitation
8 General practices
8313 Patients
Completed on-line risk
estimation
N = 96 (1.2%)
High risk score at screening
N = 65 (0.8%)
Attendance at general practice
N = 11 (0.1%)
Low risk score: N = 126
Medium risk score: N = 68
Low risk score: N = 16
Medium risk score: N = 15
Cardiometabolic morbidity
N = 25 (1.6%)
Cardiometabolic morbidity
N = 6 (0.07%)
Figure 2 Flow chart of the results of the prevention consultation cardiometabolic risk.
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are shown in Table 3. Eighteen participants (13%) had a
newly diagnosed hypertension, 15 (11%) hypercholester-
olemia, two (1%) had diabetes mellitus and two (4%) had
albuminuria. Four participants (3%) had both hyperten-
sion and hypercholesterolemia. Based on a physician’s
diagnosis of hypertension, hypercholesterolemia, dia-
betes mellitus or chronic kidney disease, a total of 31
newly diagnosed patients (22%) were identified.
Non-response
The questionnaire to assess the reasons for non-response
was sent to 3,183 patients of whom 932 (29.3%) returned
the questionnaire (427 from practices with the active
approach, and 505 from practices with the passive ap-
proach). A large proportion of patients listed in prac-
tices of the passive approach answered that they were
not familiar with the PC CMR (n = 433 (85.7%)). Of
these 433 patients, 203 (46.9%) had not visited the
practice in the past six months and have therefore not
been able to take notice of a poster of leaflet in the
practice about the PC CMR.
For the analysis of reasons for non-response data were
available of 274 patients (29% of the questionnaire re-
sponders) who reported that they only had completed
the first step of the PC CMR (the online risk estimation)
and 177 patients who were familiar with the PC CMR
(had seen or heard about it), but had not completed the
online risk estimation.
Age, gender, marital status, education level and ethnic
background did not differ between responders and non-
responders (Table 4). There were only small, non-significant
differences between responders and non-responders with re-
gard to smoking status, physical activity and body mass
index. Non-responders more often excessively used alcohol
than responders (p < 0.001) and less often had a history of
high blood sugar (p = 0.03).
The most frequently mentioned reason for not partici-
pating was the fear that online assessment is a privacy
risk (23.9%) (Figure 3). Other frequently mentioned rea-
sons were lack of time (21.4%) and fear of medical con-
sequences related to high-risk assessment (19.6%). It
must be noted that patients who did not participate
more often reported difficulties accessing the internet
than participants (24.1% vs 10.9%, p < 0.001).
Table 4 Demographic characteristics and health risk
behaviour of responders and non-responders to online
risk estimation
Completed online
risk estimation
P value
Yes
(n = 274)
No
(n = 177)
Age
40-45 yr 27.3% 29.6% 0.83
46-50 yr 13.1% 12.5%
51-55 yr 24.8% 27.3%
56-60 yr 22.5% 19.3%
61-65 yr 18.5% 15.3%
66-70 yr 2.9% 4.0%
> 70 yr 4.0% 4.5%
Gender
Male 32.5% 39.2% 0.15
Female 67.5% 60.8%
Marital status
Single 14.6% 22.2% 0.12
Partner, not living together 3.3% 2.8%
Married and/or living together 82.1% 75.0%
Level of education
Low 22.8% 28.9% 0.33
Middle 50.0% 47.4%
High 27.2% 23.7%
Ethnicity
Dutch 83.1% 87.5% 0.37
Western immigrant 9.9% 6.25%
Non-western immigrant 7.0% 6.25%
Smoking
Current smoker 16.8% 22.6% 0.18
Former smoker 43.1% 35.6%
Never smoker 40.1% 41.8%
Physical activity recommendation
Inactive lifestyle 3.7% 5.2% 0.69
Moderately active lifestyle 53.1% 54.1%
Active lifestyle 43.2% 40.7%
Body mass index (BMI)
Underweight 4.8% 7.5% 0.11
Optimal weight 45.8% 40.5%
Overweight 40.2% 36.4%
Obesity 9.2% 15.6%
Alcohol use >6 units/day
Never 65.6% 49.4% <0.001
Seldom 21.6% 21.6%
Sometimes 9.9% 21.6%
Often 2.9% 7.4%
History of high blood glucose
or diabetes
8.9% 3.5% 0.03
Table 4 Demographic characteristics and health risk
behaviour of responders and non-responders to online
risk estimation (Continued)
Family history of diabetes 31.4% 24.6% 0.12
Family history of cardiovascular
disease
33.7% 29.0% 0.29
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Discussion
We evaluated uptake rates, newly detected cardiometabolic
disease and reasons for non-response of the newly developed
Prevention Consultation cardiometabolic risk (PC CMR) in
a 6-month, multi-center implementation study. The uptake
rates of both steps of the PC CMR were substantially higher
in practices that actively invited patients to participate com-
pared to practices that only used leaflets and posters to invite
patients. In one out of five patients who attended the GP of-
fice a cardiometabolic disease, defined as hypertension,
hypercholesterolemia, diabetes or chronic kidney disease
was diagnosed. Limited access to the internet and the fear
that participation in the PC CMR is a privacy risk were the
major reasons for non-participation.
Participation
Although patients who were actively invited to partici-
pate in the health check more often participated than
patients who were passively invited, only one third of
the eligible group completed the online risk estimation.
In the Netherlands 87% of all inhabitants have home ac-
cess to internet [17], ranging from 79% in low educated
to 95% in high educated persons. Apparently, this high
internet coverage does not guarantee a high participa-
tion in an online risk estimation. Non-participants men-
tion concerns regarding privacy with online assessments
as the most important reason not to participate. Other
studies show that paper-and-pencil questionnaires, sent
to an eligible population, results in participation rates up
to 75% [18,19]. In our study the PC CMR was offered in
a non-secure, open web environment. Participants were
able to complete the online questionnaire without the
use of a log-in account or SMS authentication. It re-
mains questionable whether the use of a more secured
web environment or a better explanation about the priv-
acy within the project would increase participation.
Previous studies suggest that participants of preventive
health checks are better educated, better motivated to
look after their health and perform more health-approved
practices than non-participants [18,20,21]. However, our
evaluation shows that participation was not confined to
the worried-well: the prevalence of smoking, physical in-
activity and overweight did not differ between responders
and non-responders. It must be noted that the number of
non-Western immigrants in the analyses was low, which
is remarkable since four participating practices were lo-
cated in the multi-cultural city of Rotterdam. We recom-
mend that with further implementation of the Prevention
Consultation in the Netherlands paper questionnaires
are used beside online risk assessments and that both
paper and online questionnaires are available in diffe-
rent languages.
Detection of cardiometabolic risk factors and disease
This study identified large numbers of smokers, patients
with overweight and/or physical inactivity. Recent Dutch
guidelines (on smoking and on obesity) for primary care
emphasize the need to guide and treat patients with these
modifiable cardiovascular risk factors [7,22]. The easily ac-
cessible and integral setting of primary care is the ideal
place to guide these patients to a healthier lifestyle. More-
over, our study identified one quarter of participants with a
positive family history of cardiovascular disease or diabetes.
Although a validated treatment algorithm is lacking, inten-
sified follow-up or risk management is justifiable for this
group at relatively high risk of cardiovascular disease [8].
In 22% of patients with a high risk who attended the
practice a cardiometabolic disease (hypertension, hyper-
cholesterolemia, diabetes) was diagnosed. Obviously,
these patients may benefit from lifestyle advice and car-
diovascular follow-up assessments. Whether this group
also needs drug treatment depends on the integrated
cardiometabolic profile.
Limitations
Three issues regarding the used outcome measures need
attention. First, the diagnoses hypertension and hyper-
cholesterolemia were based on physician’s records and
100 5 15 20 25 30
Online assessment harms privacy
Lack of time
Afraid of medical consequences in case of high risk
Already yearly check-up
Did not understand invitation / poster
Afraid of high risk outcome
Afraid of problems with mortgage / insurance
Don't want to know risk profile
No influence on risk profile
Participants of online risk estimationNon-participants
Percentage (%)
NS
NS
NS
NS
NS
P<0.001
P<0.001
P<0.001
P=0.009
Figure 3 Attitude towards participating in online risk estimation of PC CMR.
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not on absolute cut-off points for blood pressure or
cholesterol. In fact, absolute cut-off points do not exist
(anymore), since cardiovascular risk management depends
on the integrated profile and not on a single blood pres-
sure (SBP) or cholesterol [13]. For example, according to
the Dutch guidelines, a 55-year old man who smokes, has
an SBP of 160 and cholesterol ratio of 8 needs drug treat-
ment, whereas a 55-year old non-smoking man with a
similar SBP of 160, but cholesterol ratio of 4 may not need
drug treatment. Although a physician’s diagnosis of hyper-
tension or hypercholesterolemia probably differs between
professionals, our approach reflects current daily medical
practice. Second, the outcome measures of this implemen-
tation study are limited by the fact that measurements
were only taken once (blood pressure, blood and urine
tests). Follow-up measurements are warranted to establish
a more valid diagnosis. Third, obviously the presented
outcomes are intermediate measures. The design and time
frame of the study did not allow analysis of endpoints
such as cardiovascular morbidity and morbidity.
Conclusion
Nationwide implementation of the Prevention Consul-
tation in general practice is likely to be successful when
patients are approached actively (with a reminder) and
are able to complete the cardiometabolic risk estimation
not only online, but also using a written questionnaire in
multiple languages. The privacy of all assessments needs
to be guaranteed and this should be made clear to eli-
gible participants.
The Prevention Consultation seems to adequately de-
tect cardiometabolic risk factors and diseases in those
patients who attend the practice. Future efforts for both
professionals and researchers should be directed towards
longitudinal follow-up, lifestyle coaching and drug treat-
ment in order to assess the effects of the Prevention
Consultation cardiometabolic risk on long-term morbi-
dity and mortality.
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